Lantheus vs Trinity Biotech: revenue, profit, margins and growth compared
Lantheus brought in $1.5B of revenue in fiscal 2025, Trinity Biotech $61.6M in fiscal 2024. Revenue changed by +0.5% at Lantheus and +8.3% at Trinity Biotech on the year before, so Trinity Biotech grew faster. Lantheus kept 15.2% of its revenue as net profit, Trinity Biotech -51.6%. Free cash flow was $354.1M at Lantheus and -$4.6M at Trinity Biotech.
Fiscal years as each company reports them; the two may end in different months.
Questions about Lantheus and Trinity Biotech
Which is bigger by revenue, Lantheus or Trinity Biotech?
Lantheus is bigger by revenue: $1.5B in fiscal 2025, against $61.6M for Trinity Biotech in fiscal 2024.
Which keeps more of its revenue as profit, Lantheus or Trinity Biotech?
Lantheus had a net margin of 15.2% in fiscal 2025; Trinity Biotech had -51.6% in fiscal 2024.
Which grew revenue faster, Lantheus or Trinity Biotech?
In their latest fiscal years revenue changed by +0.5% at Lantheus and +8.3% at Trinity Biotech.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.